A homeostase energética é controlada por fatores neurais, endócrinos, adipocitários e intestinais. O sistema nervoso central (SNC) recebe sinalização de fatores periféricos e exerce uma função fundamental no controle da homeostase energética, estando bem estabelecido que existem populações neuronais que expressam neuropeptídeos que medeiam efeitos específicos na ingestão e/ou gasto energético. O fator liberador de corticotrofina (CRF), além de seus efeitos no controle da atividade do eixo hipotálamo-hipófise-adrenal, tem sido descrito como potente neuropeptídeo anorexígeno, modulando a ingestão alimentar e o gasto energético. Foi observado que a síntese de CRF é influenciada pela leptina, que atuaria aumentando a ativação de neurônios produtores de CRF no núcleo paraventricular (PVN). Os hormônios gonadais também participam na regulação da ingestão alimentar, do peso e da composição corporal. O efeito anorexígeno do estradiol é mediado pela ativação de receptores presentes nas áreas envolvidas no controle da homeostase energética. Em trabalho prévio de nosso laboratório foi observado que o menor ganho de peso e ingestão alimentar com o tratamento com estradiol em ratas ovariectomizadas está associado à maior expressão de RNAm de CRF no PVN. Dessa forma, este trabalho visa esclarecer a participação do CRF nos efeitos do estradiol no controle da homeostase energética. Para tanto, foram utilizadas ratas Wistar adultas, pesando entre 200-230g, provenientes do Biotério Central do Campus de Ribeirão Preto USP. Todos os animais foram submetidos à cirurgia de ovariectomia bilateral. Em todos os experimentos, houve três grupos de animais: ratas ovariectomizadas (OVX), ratas ovariectomizadas com reposição de estradiol (OVX+E) e ratas ovariectomizadas com dieta pareada ao grupo OVX+E (OVX+DP). Durante os oitos dias de cada experimento, estes animais receberam injeção subcutânea de cipionato de estradiol (10 g/Kg peso corporal, Grupo OVX+E) ou veículo (óleo de milho: 0,2 mL/rata, Grupos OVX e OVX+DP) entre 8h e 10h. Para avaliarmos a participação do CRF nos efeitos da leptina nos animais castrados com e sem reposição de estradiol, foi realizado o tratamento com injeção central de leptina (10g/5L) com e sem injeção central prévia de antagonista de CRF (antisauvagina-30). Observamos que o tratamento com cipionato de estradiol causa a redução na ingestão alimentar e no ganho de peso corporal. Ainda, quando realizamos a administração central de leptina há anorexia, perda de peso corporal, aumento na expressão de UCP-1 no BAT e na ativação neuronal no ARQ. Esses efeitos são revertidos quando realizamos administração central prévia do antagonista de CRF-R2. Os dados obtidos sugerem que o estradiol aumenta a sensibilidade à leptina, sendo este efeito mediado, pelo menos em parte, pelo receptor tipo 2 do CRF. / Energy homeostasis is controlled by neural, endocrine, adipocyte and gut factors. Central nervous system plays a key role in the control of energy homeostasis; it receives signals from peripheral factors and it is well established that the hypothalamus contains neuronal populations that express important neuropeptides to the control of food intake and energy expenditure. Besides its action in the control of hypothalamus-pituitary-adrenal axis, corticotropin releasing factor (CRF), has been described as an anorexigenic neuropeptide, modulating food intake and energy expenditure. It was shown that CRF synthesis is influenced by leptin, which would act increasing CRF neuron activation in the paraventricular nucleus (PVN). Gonadal hormones also participate in the regulation of food intake, body weight and body composition. Estradiol anorexigenic effect is mediated by specific receptors located in areas involved in the control of energy homeostasis. It was previously demonstrated that the reduction of food intake and body weight gain in ovariectomized treated rats is associated with an increase in CRF mRNA expression in the PVN. The present study aimed to investigate the role of CRF on estradiol regulation of energy homeostasis. Wistar female rats, weighing 200 230g, were bilaterally ovariectomized and divided into three groups: ovariectomized rats (OVX), ovariectomized rats treated with estradiol (OVX+E) and ovariectomized rats pair-fed with OVX+E rats (OVX+PF). The animals received daily subcutaneous injections of either estradiol cypionate (10 g/Kg bw, OVX+E) or vehicle (corn oil, OVX, OVX+PF) between 8 10 am, during 8 days. To evaluate the role of CRF on leptins effects we performed intracerebroventricular (icv) injection of recombinant leptin (10g/5L) with or without previous icv treatment with CRF-R2 antagonist (ansauvagin-30). We observed that estradiol replacement in OVX rats induced lower food intake and body weight gain. Leptin icv treatment reduced food intake, body weight gain and increased UCP-1 expression in brown adipose tissue and neuronal activation in the arcuate nucleus. These effects were abolished with previous icv administration of CRF-R2 antagonist. In conclusion, our data suggest that estradiol increases central sensitivity to leptin and this effect is mediated, at least in part, by CRF type 2 receptor.

INTRODUÇÃO: A morte encefálica (ME) associa-se à instabilidade hemodinâmica, disfunção microvascular e inflamação, comprometendo a viabilidade dos órgãos para o transplante. O hormônio 17beta-estradiol caracteriza-se por seus efeitos protetores vasculares e propriedades antiinflamatórias. OBJETIVO: Neste estudo investigou-se os efeitos do 17beta- estradiol, como modulador da microcirculação, em modelo de indução rápida de morte encefálica em ratos machos. MÉTODOS: Ratos Wistar machos foram submetidos à indução rápida de morte encefálica através da insuflação intracraniana do cateter de Fogarty. Os animais foram randomizados em 3 grupos: ratos falso-operados, apenas trepanados (FO, n=11); ratos submetidos à ME (ME, n=11); ratos tratados com 17beta-estradiol (280 ug/Kg, iv) 60 minutos após a indução da ME (E2, n=11). Os experimentos foram realizados decorridos 180 minutos após a ME. A perfusão e o fluxo sanguíneo na microcirculação mesentérica foram avaliados através das técnicas de microscopia intravital e fluxometria a laser. A expressão gênica relativa da sintase endotelial do óxido nítrico (eNOS) e da endotelina-1, no mesentério e pulmão, foi avaliada por técnica de PCR (polymerase chain reaction) em tempo real. A expressão proteica de eNOS, endotelina-1, P-selectina, molécula de adesão intercelular (ICAM)-1, molécula de adesão vascular (VCAM)-1 e molécula de adesão da plaqueta/célula endotelial (PECAM)-1 foi determinada por técnica de imunohistoquímica. As alterações histopatológicas pulmonares foram analisadas por técnica histomorfométrica. A expressão da sintase induzível do óxido nítrico (iNOS) no pulmão foi determinada por técnica de imunohistoquímica. Citocinas, quimiocinas, corticosterona e 17beta-estradiol foram quantificados por enzima-imunoensaio (ELISA). RESULTADOS: O grupo ME apresentou redução da porcentagem de microvasos perfundidos ( < 30 um) no mesentério comparado ao grupo FO e ao grupo E2, decorridos 180 minutos (p=0,0117), sem alterações no fluxo sanguíneo mesentérico (p=0,3692). Houve aumento na expressão proteica (p < 0,0001) e gênica (p=0,0009) de eNOS no mesentério no grupo E2. Não houve diferenças na expressão proteica e gênica da endotelina-1 entre os grupos. A expressão de ICAM-1 nos microvasos mesentéricos aumentou no grupo ME (p < 0,0001) e a expressão de VCAM-1 foi reduzida no grupo E2 (p=0,0008). Não houve diferenças significativas na expressão de P-selectina entre os grupos (p=0,0675). As análises histopatológicas do pulmão demonstraram aumento do edema (p < 0,0001) e hemorragia (p < 0,0001) no grupo ME comparado aos grupos FO e E2, sem diferenças no número de células inflamatórias (células polimorfonucleares: p=0,4033; células linfomononucleares: p=0,5003). A expressão de iNOS no tecido pulmonar aumentou no grupo ME comparado aos grupos FO e E2 (p < 0,0001). A expressão proteica de eNOS no pulmão diminuiu nos ratos ME e aumentou nos ratos E2 (p=0,0002). A expressão proteica de endotelina-1 no pulmão assim como a expressão gênica pulmonar de eNOS e endotelina-1 não diferiram entre os grupos. Com relação à expressão de moléculas de adesão na microcirculação pulmonar observou-se que os níveis de ICAM-1 não diferiram entre os grupos (p=0,4550); os níveis de VCAM-1 reduziram-se no grupo E2 (p < 0,0001); níveis de PECAM-1 foram reduzidos nos ratos ME (p=0,0037). Observou-se aumento das concentrações séricas de TNF-alfa (p=0,0004) e redução de VEGF sérico (p=0,0380) nos ratos ME. Houve redução das concentrações séricas de CINC-1 (p=0,0020) e aumento de MCP- 1 (p=0,0094) no grupo E2. CONCLUSÃO: O tratamento com o 17beta-estradiol foi efetivo em restaurar a perfusão mesentérica e reduzir a lesão pulmonar associadas à morte encefálica. Sugere-se que o estradiol, como modulador microcirculatório, possa contribuir para a preservação dos órgãos destinados ao transplante / BACKGROUND: Brain death (BD) is associated with hemodynamic instability, microvascular dysfunction and inflammation, which compromise the viability of the organs for transplantation. The hormone 17?-estradiol is known to display vascular protective effects and anti-inflammatory properties. OBJECTIVE: This study aimed to investigate the effects of 17beta-estradiol, as a microcirculatory modulator, in a sudden onset BD model in male rats. METHODS: Male Wistar rats underwent rapid onset BD by inflating a Fogarty catheter in the intracranial space. Rats were randomly divided in three groups: sham-operated rats submitted to trepanation only (SH, n=11); rats submitted to BD (BD, n=11); and rats treated with 17beta-estradiol (E2, 280 ug/kg, iv) 60 min after BD (E2, n=11). Experiments were performed 180 min thereafter. Laser Doppler flowmetry and intravital microscopy were used to evaluate mesenteric microvascular alterations. Gene expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 in the mesentery and lungs were measured by real-time polymerase chain reaction. Protein expression of eNOS, endothelin-1, Pselectin, intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, and platelet/endothelial cell adhesion molecule (PECAM)-1 was investigated by immunohistochemistry. Lung histopathological changes were evaluated by histomorphometry and tissue expression of inducible nitric oxide synthase (iNOS) by immunohistochemistry. Cytokines, chemokines, 17beta- estradiol, and corticosterone were measured by enzyme-linked immunosorbent assay. RESULTS: The proportion of mesenteric perfused small vessels ( < 30 um diameter) was reduced in BD rats compared to SH and E2 rats at 180 min (p=0.0117), without changes in mesenteric blood flow (p=0.3692). Protein expression of eNOS was increased in E2 group (p < 0.0001), as well gene expression of eNOS (p=0.0009). There were no differences in protein and gene expression of endothelin-1 between groups. The expression of ICAM-1 on mesenteric vessels was increased in BD group (p < 0.0001) and expression of VCAM-1 was reduced in E2 rats (p=0.0008). There were no differences in the expression of P-selectin between groups (p=0.0675). Lung histopathological analyses showed increased edema (p < 0.0001) and hemorrhage (p < 0.0001) in BD group compared to SH and E2 groups, without differences in the number of inflammatory cells (polymorphonuclear cells: p=0.4033; lymphomononuclear cells: p=0.5003). The expression of iNOS on lung tissue was increased in BD group, compared with SH and E2 groups (p < 0.0001). Lung protein expression of eNOS decreased in BD rats, and increased in E2 rats (p=0.0002). Protein expression of lung endothelin-1 as well as gene expression of lung eNOS and endothelin-1 did not differ among groups. Regarding the expression of adhesion molecules on lung microcirculation, it was observed that ICAM-1 levels did not differ between groups (p=0.4550); levels of VCAM-1 decreased in E2 group (p < 0.0001); PECAM-1 levels were reduced in BD rats (p=0.0037). BD rats showed increased levels of TNF-alpha (p=0.0004), and a reduction in the levels of VEGF (p=0,0380) in the serum. BD-E2 rats exhibited reduced CINC-1 levels (p=0.0020) and increased levels of MCP-1 (p=0,0094) in the serum. CONCLUSION: Data presented showed that 17beta-estradiol treatment was effective in restoring mesenteric perfusion and reducing lung injury in braindead rats. Estradiol, as a microcirculatory modulator, is a promise therapy to improve organs viability to transplant

Muitos oxidantes químicos reativos acarretam na ruptura de estruturas moleculares complexas de vários tipos de compostos orgânicos decompondo-as em estruturas mais simples e propiciando condições melhores para uma efetiva ação de micro-organismos na degradação biológica. A presença de hormônios, entre eles o 17&beta;-estradiol, em estações de tratamento de esgoto e em águas subterrâneas e superficiais mostra a necessidade de uma avaliação dos processos de tratamento convencionais. O objetivo deste trabalho foi a análise e remoção de hormônios através de técnicas de cloração e ozonização de amostras reais de águas de saída de filtro de estações de tratamento de água (ETAs), operadas pelo Serviço Autônomo de Água e Esgoto (SAAE) de São Carlos (ETA Centro), que capta águas dos ribeirão Feijão e córrego Espraiado e pela Sociedade de Abastecimento de Água e Saneamento S/A (SANASA) de Campinas (ETAs 3 e 4), que capta águas do rio Atibaia. Foram realizados ensaios contaminando-se as amostras com 17&beta;-estradiol, que é o hormônio natural mais presente no meio ambiente, em concentração de 6.000 ng L-1, submetendo-se tratamento com dosagens em torno de 0,5 e 2,0 mg L-1 desses oxidantes, em tempos de contato de, respectivamente, 10 e 30 min. As amostras submetidas à contaminação e tratamento e as de controle (sem contaminação e tratamento) foram analisadas através da remoção do 17&beta;-estradiol com a verificação da atividade estrogênica das amostras por ensaios de Sistema de Expressão de Estrogênio Induzida por Levedura Bioluminescente (BLYES), que apresentou-se como uma ferramenta simples. Os resultados apresentados neste trabalho demonstram que a oxidação por ozônio se mostrou mais eficiente do que aquela por cloro para a remoção da atividade estrogênica causada, única e exclusivamente, pelo 17&beta;-estradiol para uma dosagem inicial desse hormônio relativamente alta (6.000 ng L-1). Todavia, em todos os ensaios a concentração final da atividade estrogênica permaneceu acima do limite de quantificação desses hormônio, indicando que a remoção não foi completa, mesmo em condições favoráveis, isto é, matriz limpa, com padrões de potabilidade para os parâmetros físico-químicos. / Many reactive chemical oxidants cause the disruption of the complex molecular structures of various types of organic compounds decomposing them into simpler structures and providing better conditions for effective action of micro-organisms in the biological degradation. The presence of hormones, including 17&beta;-estradiol in sewage treatment plants and groundwater and surface water shows the need for an evaluation of conventional treatment processes. The aim of this study was the analysis and removal of hormones through techniques of chlorination and ozonation of real samples of output filter water in water treatment plants (WTP), operated by the Serviço Autônomo de Água e Esgoto (SAAE) of São Carlos (Center WTP), which captures waters from Espraiado stream and Feijão stream and the Sociedade de Abastecimento de Água e Saneamento S/A (SANASA) de Campinas (WTPs 3 and 4), which captures water from the Atibaia river. Assays were performed contaminating the samples with 17&beta;-estradiol, which is the natural hormone more present in the environment, in a concentration of 6.000 ng L-1 submitting themselves to treatment with dosages of around 0.5 to 2.0 mg L-1 of these oxidants in times of contact, respectively, 10 and 30 min. The samples subjected to contamination and treatment and control samples (without contamination and treatment) were analyzed by removing 17&beta;-estradiol with estrogenic activity verification of the samples by Bioluminescent Assays or Estrogen-Inducible Yeast Expression System (BLYES), which was presented as a simple tool. The results presented here demonstrate that the oxidation by ozone was more effective than with chlorine to remove estrogenic activity caused solely by 17&beta;-estradiol for an initial dosage of the hormone relatively high (6000 ngL -1) However, in all experiments the final concentration of estrogenic activity remained above the limit of quantification of these hormones, indicating that removal was not complete, even under favorable conditions, clean matrix with quality for drinking water physico-chemical parameters.

Submitted by Renata Lopes (renatasil82@gmail.com) on 2016-09-20T18:17:08Z No. of bitstreams: 1 adrianakarlagaviosilva.pdf: 1087827 bytes, checksum: c5a343cea0fe929422a92846e99a422c (MD5) / Approved for entry into archive by Diamantino Mayra (mayra.diamantino@ufjf.edu.br) on 2016-09-26T20:24:59Z (GMT) No. of bitstreams: 1 adrianakarlagaviosilva.pdf: 1087827 bytes, checksum: c5a343cea0fe929422a92846e99a422c (MD5) / Made available in DSpace on 2016-09-26T20:24:59Z (GMT). No. of bitstreams: 1 adrianakarlagaviosilva.pdf: 1087827 bytes, checksum: c5a343cea0fe929422a92846e99a422c (MD5) Previous issue date: 2010-03-26 / FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais / A Esclerose Múltipla (EM) é uma doença inflamatória, crônica e desmielinizante do sistema nervoso central (SNC). Embora ela seja, ainda, de etiologia desconhecida, é considerada uma doença auto-imune mediada por linfócitos T “helper” 1 (Th1) e T “helper” 17 (Th17) e com predominância em mulheres. Contudo, as bases para esta predominância ainda não estão bem elucidadas. Os primeiros sintomas da EM, normalmente, surgem após a maturidade sexual. Por outro lado, níveis elevados de hormônios sexuais durante o período de gravidez parecem reduzir os sinais e sintomas, os quais aumentam no período pós-parto. A Encefalomielite auto-imune experimental (EAE) é o modelo animal mais usado para estudar a EM. Assim, este estudo teve como objetivo avaliar os efeitos do tratamento com 17 β-Estradiol na prevenção da EAE murina. Os resultados indicaram que o tratamento com este hormônio melhorou o curso clínico da doença, diminuiu a concentração de citocinas pró-inflamatórias, como interferon-gama (IFN-γ), fator de necrose tumoral-alfa (TNF-α) e interleucina 17 (IL-17), e a infiltração de leucócitos no SNC, além de aumentar os níveis da interleucina 10 (IL-10). Houve, também, um aumento de linfócitos B no cérebro e baço dos animais submetidos ao tratamento. Portanto, o 17 β-Estradiol parece desempenhar um papel imunomodulador na EAE. / Multiple Sclerosis (ME) is an inflammatory, chronic and demyelinating disease of the central nervous system (CNS). Although the etiology of it is still unclear, it is considered a CD4+ T Helper-1-mediated and CD4+ T Helper-17-mediated autoimmune disease and the highest prevalence of it is in women. However, the basis for this prevalence isn´t still well clear. The first symptoms of ME, often, appear after sexual maturity. On the other hand, high levels of sexual hormones during pregnancy seems to low signs and symptoms, which to be high after childbirth. Experimental autoimmune encephalomyelitis (EAE) is an animal model to study ME. Therefore, the aim of this study was to investigate the effects of treatment with 17 β-Estradiol on murine EAE. Results indicated that the treatment with this hormone ameliorated the clinical course of the disease, decreased pró-inflammatory cytokines levels, like interferon-gamma (IFN-γ), tumor necrosis factor alpha (TNF-α) e interleucine 17 (IL-17), and infiltration of white blood cells on CNS, further on increased interleucine 10 (IL-10) levels. There was also an increased of B cells in brain and spleen of treated animals. In conclusion, 17 β-Estradiol may play an immunomodulatory role in EAE.

Les oestrogènes font partie de la famille des neurostéroïdes. Notamment, l’Estradiol (17β-E2) pourrait avoirdes effets bénéfiques sur certaines anomalies liées à l'âge (déclin mnésique et cognitif, maladie d'Alzheimer). Le dosagede très faibles teneurs du 17β-E2 et de ces métabolites (Estrone, Estriol), dans les tissus cérébraux et le plasma, constitueun outil indispensable pour estimer la variation de leurs niveaux avec l'âge et dans différentes pathologies.Tout d'abord, nous avons élaboré une méthode en RP-HPLC-ESI(-)-MS/MS de quantification des oestrogènes sansdérivation chimique. La sélectivité de la séparation et la sensibilité de la détection de ces molécules ont été amélioréesaprès optimisation des paramètres MRM et chromatographiques.Puis, différents agents de dérivation ont été synthétisés et évalués afin d’augmenter le taux d’ionisation pour améliorerla sensibilité de détection. Après l’analyse ESI-MS et MS/MS de onze dérivés du 17β-E2, nous nous sommes intéressésplus particulièrement au dérivé 17β-E2-Q8S.Afin de réduire les interférences, une méthode de préparation de l’échantillon biologique (tissus cérébral, plasma desouris) a été développée. Les deux dosages (sans et avec dérivation) ont été comparées en termes de sensibilité, limitesde détection et de quantification (LD et LQ), linéarité et reproductibilité. Puis, elles ont été appliquées à l’analyse deséchantillons de cerveau, d'hippocampe et de plasma prélevés sur des animaux jeunes et âgés traités avec des quantitésconnues de 17β-E2. La méthode qui nous est apparue la plus robuste est la méthode sans dérivation avec une LD de0,5 fmole.μL-1. / Estrogens are neurosteroids, especially Estradiol (17β-E2) which is considered to be the most biologicallyactive form. 17β-E2 could have positive effects on some age-associated anomalies (memory and cognitive impairment,Alzheimer's disease). For elucidating and better understanding the molecular and cellular mechanisms that underliethe effects within the brain, it is necessary to quantitate 17β-E2 and its metabolites (estrone and estriol) in brain andplasma.First, the RP-HPLC-ESI(-)-MS/MS method without derivatization was developed. The selectivity of the separationand the sensitivity of detection of the estrogens has been improved after optimization of MRM and chromatographicparameters.Secondly, the various derivatization agents were evaluated after their synthesis in order to improve the sensitivity,selectivity and signal enhancement. After studying the eleven synthesized derivatives of 17β-E2 in ESI-MS andMS/MS, promising results were obtained with the 17β-E2-Q8S derivative.A simple purification method using liquid-liquid extraction followed by C18 solid phase extraction has been optimizedin order to minimize assay interferences. The two assays (with and without derivatization) were then compared interms of efficiency, detection and quantification limits (LOD/LOQ), calibration linearity and reproducibility. Then,both methods were validated on biological samples (brain, hippocampus and plasma) collected from animals treatedwith known amounts of 17β-E2. Finally, the more robust method was the method without derivatization with a LODof 0.5 fmol.μL-1.

Made available in DSpace on 2016-01-26T18:55:28Z (GMT). No. of bitstreams: 1 Dissertacao.pdf: 210803 bytes, checksum: 83b85718d8feaeb1014019b6a6feaea9 (MD5) Previous issue date: 2009-08-11 / The aim of study was to test the hormonal protocol for FTAI (fixed timed artificial insemination) with progesterone for 6 days applying eCG (Equine Corionic Gonadotrophin) or BE (Estradiol Benzoate) and induction of estrus using: MAP (acetato de medroxiprogesterone) for 6, 9 and 14 days or a single dose of PGF2a or male effect. Experiment 1: In D0 each ewe (n = 31) received CIDR being divided into 3 groups: GC (control) CIDR for 9 days and in withdrawal PGF2a + eCG. In G-eCG CIDR for 6 days PGF2a + eCG and in G-BE estradiol benzoate 24H after PGF2a and the FTAI 50H after the withdraw of CIDR. Experiment 2: On day 0 the sheeps (n = 48) received MAP being divided into 2 groups: G-9 and G-14 MAP by 9 or 14 days + PGF2a in withdrawal and detection of estrus. Experiment 3: divided up the sheeps (n = 151) in 3 groups: the G-6, each ewe received MAP for 6 days + PGF2a in withdrawal, the G-PGF, each ewe received PGF2a and G-EF only introducing ruffians. In exp. 1 pregnancy in the G-eCG (66%) was higher (p <0.05) in which G-BE (11.1%). In exp. 2 there were no differences (p <0.05) in estrus, pregnancy rate or design and in exp. 3 in G-6 (58%) and G-PGF (39%) the rate of estrus was greater (p <0.05) than in G-EF (11%). We concluded that is possible to reduce the time of permanence of progesterone using eCG for FTAI in sheep. / Objetivou-se testar o protocolo hormonal para IATF (inseminação artificial em tempo fixo) com progesterona por 6 dias aplicando-se eCG (gonadotrofina Coriônica Eqüina) ou BE (Benzoato de Estradiol) e indução de estros utilizando-se: esponjas vaginais impregnadas com MAP (acetato de medroxiprogesterona) por 6, 9 e 14 dias ou dose única de PGF2a ou efeito macho. Experimento 1: No D0 cada ovelha (n=31) recebeu CIDR sendo divididas aleatoriamente em 3 grupos: G-C (controle) CIDR por 9 dias e na retirada PGF2a + eCG. No G-eCG CIDR por 6 dias + PGF2a + eCG e no G-BE Benzoato de estradiol 24h após a PGF2a e a IATF 50 h após a retirada do CIDR. Experimento 2: No dia 0 as ovelhas (n=48) receberam MAP sendo divididas em 2 grupos: G-9 e G-14 MAP por 9 ou 14 dias + PGF2a na retirada e detecção de estro. Experimento 3: Dividiu-se aleatoriamente as ovelha (n=151) em 3 grupos: o G-6, cada ovelha recebeu MAP por 6 dias + PGF2a na retirada; o G-PGF, cada ovelha recebeu PGF2a e o G-EF apenas introdução de rufiões. No exp. 1 a prenhez no G-eCG (66%) foi maior (p<0,05) que no G-BE (11,1%). No exp. 2 não houve diferenças (p<0,05) no estro, taxa de prenhez ou de concepção. No exp. 3 no G-6 (58%) e G-PGF (39%) a taxa de estro foi maior (p<0,05) que no G-EF (11%). Concluímos ser possível reduzir o tempo de permanência da progesterona usando eCG para IATF em ovelhas

Made available in DSpace on 2016-07-18T17:53:06Z (GMT). No. of bitstreams: 1 Dissertacao.pdf: 210803 bytes, checksum: 83b85718d8feaeb1014019b6a6feaea9 (MD5) Previous issue date: 2009-08-11 / The aim of study was to test the hormonal protocol for FTAI (fixed timed artificial insemination) with progesterone for 6 days applying eCG (Equine Corionic Gonadotrophin) or BE (Estradiol Benzoate) and induction of estrus using: MAP (acetato de medroxiprogesterone) for 6, 9 and 14 days or a single dose of PGF2a or male effect. Experiment 1: In D0 each ewe (n = 31) received CIDR being divided into 3 groups: GC (control) CIDR for 9 days and in withdrawal PGF2a + eCG. In G-eCG CIDR for 6 days PGF2a + eCG and in G-BE estradiol benzoate 24H after PGF2a and the FTAI 50H after the withdraw of CIDR. Experiment 2: On day 0 the sheeps (n = 48) received MAP being divided into 2 groups: G-9 and G-14 MAP by 9 or 14 days + PGF2a in withdrawal and detection of estrus. Experiment 3: divided up the sheeps (n = 151) in 3 groups: the G-6, each ewe received MAP for 6 days + PGF2a in withdrawal, the G-PGF, each ewe received PGF2a and G-EF only introducing ruffians. In exp. 1 pregnancy in the G-eCG (66%) was higher (p <0.05) in which G-BE (11.1%). In exp. 2 there were no differences (p <0.05) in estrus, pregnancy rate or design and in exp. 3 in G-6 (58%) and G-PGF (39%) the rate of estrus was greater (p <0.05) than in G-EF (11%). We concluded that is possible to reduce the time of permanence of progesterone using eCG for FTAI in sheep. / Objetivou-se testar o protocolo hormonal para IATF (inseminação artificial em tempo fixo) com progesterona por 6 dias aplicando-se eCG (gonadotrofina Coriônica Eqüina) ou BE (Benzoato de Estradiol) e indução de estros utilizando-se: esponjas vaginais impregnadas com MAP (acetato de medroxiprogesterona) por 6, 9 e 14 dias ou dose única de PGF2a ou efeito macho. Experimento 1: No D0 cada ovelha (n=31) recebeu CIDR sendo divididas aleatoriamente em 3 grupos: G-C (controle) CIDR por 9 dias e na retirada PGF2a + eCG. No G-eCG CIDR por 6 dias + PGF2a + eCG e no G-BE Benzoato de estradiol 24h após a PGF2a e a IATF 50 h após a retirada do CIDR. Experimento 2: No dia 0 as ovelhas (n=48) receberam MAP sendo divididas em 2 grupos: G-9 e G-14 MAP por 9 ou 14 dias + PGF2a na retirada e detecção de estro. Experimento 3: Dividiu-se aleatoriamente as ovelha (n=151) em 3 grupos: o G-6, cada ovelha recebeu MAP por 6 dias + PGF2a na retirada; o G-PGF, cada ovelha recebeu PGF2a e o G-EF apenas introdução de rufiões. No exp. 1 a prenhez no G-eCG (66%) foi maior (p<0,05) que no G-BE (11,1%). No exp. 2 não houve diferenças (p<0,05) no estro, taxa de prenhez ou de concepção. No exp. 3 no G-6 (58%) e G-PGF (39%) a taxa de estro foi maior (p<0,05) que no G-EF (11%). Concluímos ser possível reduzir o tempo de permanência da progesterona usando eCG para IATF em ovelhas

Osmotic swelling of glial cells may contribute to the development of retinal edema. We investigated whether sex steroids inhibit the swelling of glial somata in acutely isolated retinal slices and glial cells of the rat. Superfusion of retinal slices or cells from control animals with a hypoosmolar solution did not induce glial swelling, whereas glial swelling was observed in slices of postis- chemic and diabetic retinas. Progesterone, testosterone, estriol, and 17ß-estradiol prevented glial swelling with half-maximal effects at approximately 0.3, 0.6, 6, and 20 lM, respectively. The effect of progesterone was apparently mediated by transactivation of metabotropic glutamate receptors, P2Y1, and adenosine A1 receptors. The data suggest that sex steroids may inhibit cytotoxic edema in the retina.

Corpus luteum is a transient endocrine structure formed from the ruptured ovarian follicle. Its main function is to secrete P4, a pro-gestational hormone, essential for establishment and maintenance of pregnancy in mammals. The modulators of CL structure and function are classified as trophic and lytic factors. The luteotrophic factors include pituitary hormones, growth factors, intra luteal factors and cytokines, while luteolytic factors include PGF2α and oxytocin. The interplay between luteotrophic and luteolytic factors regulates luteal steroidogenesis. The precise timing of expression of various enzymes/proteins required for synthesis and metabolism of P4 constitutes an important process in the overall regulation of CL function. The three hormones LH/CG, E2 and PRL are regarded as luteotrophic factors crucial for control of CL function in mammals. Depending on species, either individually or all three hormones in the form of luteotrophic complex have been shown to participate in the regulation of CL function. In addition to the well-established endocrine role of E2, its secretion is the hallmark of the ovulating follicle, has an important role in the intraovarian growth, differentiation and survival of cells. Chapter I provides a comprehensive review of literature on CL structure and function with emphasis on factors that influence its growth, development, function and demise in bovines and rodents. In Chapter II, studies have been carried out to examine 20α-HSD expression and its activity in the CL of buffalo cow. During induced and spontaneous luteolysis, rapid fall in circulating P4 is one of the early signs of initiation of luteolytic process in several species. In rodents, it is well recognized that during luteolysis, P4 is catabolized into inactive metabolite, 20α-OHP by the reaction of 20α-HSD enzyme during luteolysis. Experiments were carried out to determine 20α-HSD expression and activity throughout the luteal phase and during induced luteolysis in the buffalo cow. Circulating P4 concentration declined rapidly in response to PGF2α treatment, but HPLC analysis of serum samples did not reveal changes in circulating 20α-OHP levels in buffalo cows. In contrast, pseudo pregnant rats receiving PGF2α treatment showed higher 20α-OHP levels at 24 h post treatment. qPCR expression of 20α-HSD in CL during different stages of luteal phase and PGF2α-treated buffalo cows was carried out and higher expression of 20α-HSD was observed at 3 and 18 h post treatment, but its activity was not altered post PGF2α treatment at other time points examined. The expression of the transcription factor Nurr77 which is involved in increased expression of 20α-HSD increased several fold 3 h post PGF2α treatment similar to the observation in PGF2α-treated pseudo pregnant rats. The results suggested that the synthesis rather than catabolism of P4 appears to be primarily affected by PGF2α treatment in buffalo cows in contrast to increased metabolism of P4 as seen in rodents. In bovines, to date no luteotropic actions for E2 has been demonstrated and whether E2 has direct effect on CL function has also not been reported. Expression of CYP19A1 gene that encodes aromatase enzyme although gets down regulated post ovulation but its expression recovers in the CL and also E2 biosynthesis has been reported in the bovine CL. Recently it was observed that CYP19A1 expression was consistently down regulated following administration of luteolytic dose of PGF2α. Experiments were conducted to examine the expression of ERα and ERβ in the CL throughout the buffalo estrous cycle as well as examined the luteal E2 levels post PGF2α treatment. The results indicated that ER expression was detectable during different stages of CL and that circulating and luteal E2 levels declined post PGF2α treatment. It was hypothesized that decrease in luteal E2 levels leads to down regulation of ER signaling and changes in expression of E2 responsive genes in the CL. To test the hypothesis, 89 genes which were regarded as E2 responsive genes were selected and the previously published global gene expression data of the buffalo CL was mined for E2 responsive genes. It was observed that 57 of 89 genes regarded as E2 responsive genes were found to be differentially expressed. Since non pregnant buffalo CL is not regarded as major site of E2 production, to validate the authenticity of differentially E2 expressed genes post PGF2α, CL of another species, the macaque, which is known to secrete abundant E2 was included for the analysis. Incidentally, the global gene expression data for the PGF2 α treated macaques (in which CYP19A1 gene expression also gets down regulated) has previously been reported from the laboratory. Here again, it was observed that nearly 79 of 89 genes were identified to be differentially expressed. To further determine the consequences of decreased ER signaling, molecules associated with survival and apoptosis were examined. The results indicated decreased expression (both mRNA and protein levels) of Akt, Bax and Bcl-2 genes. The results suggested an important role for E2 on CL function in the buffalo cow. In Chapter III, several experiments were conducted in another model system, pregnant rat, in which aromatase expression and therefore E2 production is high in the CL. Experiments were conducted to examine the effects of E2 inhibition and E2 replacement on the expression of genes. For this purpose, pregnant rats were treated with a specific aromatase inhibitor on day 12-15 of pregnancy. Together with AI, exogenous E2 was administered to another group of pregnant rats. The CL collected from different groups of rats on day 16 of pregnancy was subjected to microarray analysis. The analysis post validation of microarray data has shown that clusters of genes could be segregated into various pathways involving luteal steroidogenesis, immune system, various growth factors and apoptotic processes, all directed towards the regulation of CL function. The involvement of E2 in luteal cell proliferation and lipid deposition well corroborated with protein levels for cyclin D1 and ki67 and the results of oil red O staining, respectively. There have been reports implicating PI3K/Akt signaling in cyclin D1 accumulation, but mechanism of action does not appear to involve transcriptional activation of cyclin D1. The results of the present study indicate a decrease in cyclin D1 protein levels due to inhibition of PI3K/Akt signaling by AI treatment which is prevented upon administration of E2 during AI treatment. The findings provide a comprehensive overview for the mechanisms associated with the cell survival, progression, etc. The bioinformatics approach provided complete landscape of functional changes affected by the upstream regulators of genes associated with survival and apoptosis. Also, the findings further strengthen the hypothesis of involvement of E2 in the regulation of CL function by way of activation of Akt, the primary mediator of PI3K signaling in the regulation of cellular component that affect cell survival. In the present study, IGFBP5 which was up regulated during luteal inhibition of E2 with AI treatment was selected for further studies. Although IGFBP5 is known to be associated with follicular atresia in the rat ovary, there is limited data for the involvement of IGFBP5 in either a growth stimulatory or inhibitory action on ovarian cells. Based on present findings, a causal link between reduced ERα transcriptional activities resulting in inhibition of Akt/PKB in the presence of IGFBP5 expression could be proposed. Further, the cellular hypertrophy mediated by E2 has been speculated due to increased proliferation of vascular endothelial cells, blood supply and thus nutrients. E2, together with PRL and placental lactogens, regulates steroidogenesis and cell hypertrophy in the rat CL of pregnancy. In CL, the prominent IGFBP5 mRNA expression in different types of luteal cells has not been reported. The mRNA expression for IGFBP5 across the two types of luteal cells showed higher expression in SLC. Hence, in the present study, it has been speculated that prevention of conversion of SLC to LLC due to lack of E2 biosynthesis in presence of AI might be acting as a source for the increased IGFBP5 levels during mid pregnancy in rat CL and brings about changes associated with lack of E2. Various receptor studies on rat CL have demonstrated the lack of progesterone receptor (PR) mRNA expression in the rat CL negating its involvement as an autocrine/paracrine regulator of CL function through an intracellular receptor, but the involvement of non-PR involvement in mediating such mechanism further strengthens the role of ERs. The luteotrophic complex formation in pregnant rat principally by PRL and E2 has been discussed at length in Chapter III. PRL appears to maintain luteal ER content in the CL during rat pregnancy which further determines the luteotrophic and luteolytic actions of E2. Further, study on expression of E2 responsive genes would help in identifying E2 regulating molecules to get a clear picture on the role of E2 in understanding regulation of the CL function. The interaction of E2 with growth factor signaling including the IGF pathway has been well established in different species and this interaction is tightly linked to ERα expression, an observation interpreted as physiological coupling of growth factor and stress signaling pathways. Attempts were made towards understanding cross talk between the E2 signaling and the IGF1 signaling in few experiments carried out in Chapter IV. Based on the results, it can be proposed that a causal link exists between reduced ERα transcriptional activity and inhibition of Akt/PKB in the presence of IGFBP5. The present study has shown the activity of IGF on ERα activity mediated partly via PI3K/Akt pathway. Hence, the finding further speculates that inhibitory effect of IGFBP5 on E2 induced ERα function was due to sequestration of IGF1, possibly present in serum or produced within the cells. Another striking observation was the down regulation of glucocorticoid receptor (GR) gene, NR3C1, in the data of earlier studies [Priyanka, 2009, GEO accession number GSE8371 and Kunal, 2014, GEO accession number GSE27961] and the present study has been compared and discussed in this thesis. Glucocorticoids provide key signals for differentiation of fetal and placental tissues. Therefore, regulation of glucocorticoid access to the placenta and fetus is recognized as an important determinant of prognosis outcome and subsequent development of the postnatal phenotype. Differential regulation of these genes in CL post E2 deprivation and replacement further emphasize the regulation of CL via various biological, cellular and molecular functions. Interestingly, besides transcriptional regulation of IGF axis components, E2 activated ERα also rapidly influence the activity of IGF axis related to signaling proteins in a non-genomic manner, especially by the PI3K/Akt pathway. PI3K/Akt pathway analysis has been carried out in E2 inhibition and replacement experiments. To further confirm the observations of E2 and growth factor interaction, experiments have been set up with exogenous GH for increasing circulating levels of IGF in the system. The findings suggest that the non-genomic signaling pathway activated by the phosphorylation of ERα induced by E2 gets inhibited in the presence of AI result in increased expression of IGFBP5. The reduction in circulating IGF1 in pregnant rats may be associated with the effect on IGFBP, important for determining biological action of IGF1. The changes observed in the present study emphasize the exclusive effects of the IGFBP5 on the CL function brought about perturbations in luteal E2 content. The experiments described in the present thesis aim at understanding the mechanism responsible for decreased serum and luteal P4 post PGF2α treatment in buffalo cows, i.e. whether PGF2α acts on biosynthetic or catabolic process of P4. In the present study, experiments were designed to elucidate the role of E2 in regulation of CL function, since down regulation of CYP19A1 gene mRNA was one of the early events observed in buffalo cows post PGF2α treatment. This line of research work was extended to rodents, a species that secretes high levels of E2 during pregnancy. Genome wide transcriptional changes data revealed differential expression of several E2 responsive genes following E2 inhibition and replacement treatments. The results revealed importance of ER-mediated PI3K/Akt signaling essential for regulation of many transcriptional regulatory molecules in the CL and an interesting involvement of IGFBP5 as a link between E2 and IGF signaling. These findings further provide an insight into the role of IGFBP5 in E2-mediated actions in rat CL during pregnancy. In conclusion, the present findings suggest inhibitory effect of IGFBP5 on E2-induced ERα function and hence, its selection as a target molecule for regulation of CL function and for many beneficial processes involved in anti-carcinogenic properties can be thought of.

Micro-pollutants such as 17β-estradiol (E2) have been detected in different water resources and their negative effects on the environment and organisms have been demonstrated. It is essential to confirm the presence of micro-pollutants in different environments by biosensors and to remove these compounds. In this thesis, E2-binding target structures were used to investigate the underlying binding properties. E2-binding protein, DNA-, and PNA-aptamere (peptide nucleic acid) structures were used as targets to determine physicochemical interactions. The protein dataset consist of 35 publicly accessible three-dimensional structures of E2-protein complexes, from which six representative binding sites could be selected. There is no three-dimensional structure information for an E2-specific DNA aptamer, thus it was modeled using a coarse-grained modeling method. Using sequence information additional DNA aptamers were modeled. The E2 ligand was positioned close to the potential binding area of the aptamer structures, the underlying complexes were investigated by a molecular dynamics simulation, and the interactions were examined by an interaction profiler tool for each time step. A PNA generator was developed that can convert DNA and RNA in silico to more robust, but chemically equivalent PNA. This generator was used to transform the E2-specific DNA aptamer into PNA for binding studies with E2. All formed complexes were investigated with respect to the following non-covalent interaction types: hydrogen bonds, water-mediated hydrogen bonds, π-stacking, and hydrophobic interactions. Ten functional groups could be derived which formed the conserved interactions to E2. The study contributes to the understanding of the behavior of ligands that bind through different target structures in an aqueous solution and to the identification of binding specific interaction partners. The results of this thesis can be used to design novel synthetic receptor and filter systems.